Two federal grants totaling $6.1 million were awarded to Vanderbilt University Medical Center (VUMC) and the Translational Genomics…
Articles by Ana Pena, PhD
Saracatinib (AZD0530), an investigational oral therapy under development by AstraZeneca,…
Exposure to silica dust may trigger pulmonary fibrosis (PF) because silica particles block a self-cleansing process…
The Envisia Genomic Classifier, Veracyte‘s genomic test for improved…
The U.S. Food and Drug Administration (FDA) has cleared the way for…
One year of treatment with Genentech‘s Esbriet (pirfenidone) significantly…
Panobinostat, an approved treatment for multiple myeloma, exerts anti-fibrotic activity, inducing cell death and reducing the proliferation of…
RXC006, an oral treatment candidate for idiopathic pulmonary fibrosis (IPF)Â and other types of fibrosis, was seen to ease lung…
A herbal extract derived from a product used in Korean traditional medicine may be a potential alternative treatment…
Researchers have uncovered an immunological mechanism that underlies fibrosis in different lung conditions, including…